Search

everythinglearnresearchcommunity

for

Search:↓

ODC1 gene mutations cause a neurodevelopmental disorder with large head size, hair loss, and facial abnormalities.

EGFR inhibitors can cause skin issues, and managing these is important for treatment success.

Chemotherapy-induced hair loss is a major concern, but various treatments show promise in preventing and reversing it.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Cox-2 significantly contributes to the development and progression of skin and esophageal cancers.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

New treatments targeting the Hedgehog pathway can help treat advanced skin cancer but may have side effects and their effectiveness in early stages is unknown.

Wnt-activating drugs generally do not increase cancer risk.

New CRISPR/Cas9 variants and nanotechnology-based delivery methods are improving cancer treatment, but choosing the best variant and overcoming certain limitations remain challenges.

Certain proteins can either protect against or increase the risk of hypertrophic scars.

Skin tumors with CYLD cutaneous syndrome show more NF-κB activity and less organized collagen.

New cancer treatments aim to reduce side effects and improve effectiveness.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

Primary healthcare clinics are key in managing chemotherapy side effects using various medications and treatments.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

ICI therapy increases the risk of gastrointestinal and endocrine issues in psoriasis patients.

The document concludes that careful diagnosis is crucial for chromosome 13q deletion syndrome, tamoxifen can cause reversible eye damage, finasteride may be linked to cataracts, and OCT is useful for diagnosing macular diseases.

Inducing survivin in normal tissues can protect against radiation damage.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

Melanocyte pathology requires keratinocyte hyperplasia and regulation dysfunction.

Rare skin cancer can mimic hair loss conditions, so thorough diagnosis is crucial.

Keloid scars may form due to changes in skin cell characteristics and specific protein signaling.

Blocking S100A8 can reduce chemotherapy-induced hair loss.

A virus protein can activate a pathway that may lead to abnormal hair follicle development.

Transplant patients face higher skin cancer risks due to immunosuppressive therapy, requiring careful skin health monitoring.

Overexpression of certain genes can shorten hair by disrupting the hair-growth cycle.

Basal cell carcinomas may use IDO to protect themselves from the immune system.